Found 6 results
Author [ Title(Desc)] Type Year
Filters: Author is Blodi, Barbara A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., King, J., Antoszyk, A. N., Peters, M. A., and Tolentino, M., “Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4”, JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
C
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Altaweel, M., and Berinstein, D. M., “Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial”, JAMA Ophthalmol, vol. 136, no. 4, pp. 337-345, 2018.
E
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Awh, C. C., Kunimoto, D. Y., Marcus, D. M., Wroblewski, J. J., and King, J., “Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial”, JAMA, 2017.
L
J. S. Peterson, Rockwell, K., Scott, I. U., Ip, M. S., VanVeldhuisen, P. C., and Blodi, B. A., “Long-Term Physical Stability, Sterility, and Anti-VEGF Bioactivity of Repackaged Bevacizumab in 2-ML Glass Vials”, Retina, 2018.
P
I. U. Scott, VanVeldhuisen, P. C., Barton, F., Oden, N. L., Ip, M. S., Blodi, B. A., Worrall, M., and Fish, G. E., “Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial”, JAMA Ophthalmol, vol. 137, no. 8, pp. 932-938, 2019.
S
I. U. Scott, Figueroa, M. J., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., “SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion”, Am J Ophthalmol, vol. 184, pp. 147-156, 2017.